BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1305 related articles for article (PubMed ID: 12847688)

  • 1. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
    Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
    J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
    Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
    J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
    Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
    Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
    Weissbrich B; Süss-Fröhlich Y; Girschick HJ
    Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome.
    Chen DY; Tzang BS; Chen YM; Lan JL; Tsai CC; Hsu TC
    Clin Chim Acta; 2010 Aug; 411(15-16):1084-9. PubMed ID: 20385113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
    Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
    Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
    Chehadeh W; Halim MA; Al-Nakib W
    Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
    Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
    Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
    Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
    J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
    Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
    Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
    Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
    J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
    Lehmann HW; Kühner L; Beckenlehner K; Müller-Godeffroy E; Heide KG; Küster RM; Modrow S
    J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
    Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like presentation of parvovirus B19 infection.
    Sève P; Ferry T; Koenig M; Cathebras P; Rousset H; Broussolle C
    Semin Arthritis Rheum; 2005 Feb; 34(4):642-8. PubMed ID: 15692957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.